Cancer is pushing many patients in Europe in financial dire straits – even in countries with strong healthcare systems.

A new #EuropeanFairPricingNetwork study shows that patients lose income, face additional costs & skip care after diagnosis.

🔗 buff.ly/3XipCCz

💶🤝 Together with the #EuropeanFairPricingNetwork, we call for fair prices for cancer medicines and a pharmaceutical market which puts patients first.

Learn more about this initiative from ECL, @nkinl.bsky.social, @komoptegenkanker.bsky.social, @krebsliga.bsky.social, and many others: www.efpn.eu

The results, based on a survey of more than 2,500 cancer patients across 25 European countries, are a cause for concern:

💰 56% lost income
💰 28% saw their income drop with up to €800/month
💰 86% faced extra costs & 16% delayed or skipped care

#EuropeanFairPricingNetwork

New #EuropeanFairPricingNetwork research shows that some hospitals pay more than double for the exact same cancer drug.

Confidential price negotiations are leaving hospitals in the dark, weaking their bargaining power and deepening inequalities across the EU ➡️ www.nki.nl/news-events/...

Cancer is pushing many patients in Europe in financial dire straits – even in countries with strong healthcare systems.

A new #EuropeanFairPricingNetwork study shows that patients lose income, face additional costs & skip care after diagnosis ➡️ www.nki.nl/news-events/...

🚨 New #EuropeanFairPricingNetwork research shows that some hospitals pay more than double for the exact same cancer drug.

Confidential price negotiations are leaving hospitals in the dark, weaking their bargaining power and deepening inequalities across the EU.

🔗 buff.ly/t7VKfrT

Confidential price negotiations are leaving hospitals in the dark, weaking their bargaining power and deepening inequalities across the EU.

Read more about our recent #EuropeanFairPricingNetwork study from the @eurcorrespond.bsky.social ⤵️